MedPath

Gene expression profiling of healthy lymphoid precursor cells

Recruiting
Conditions
healthy volunteers
Registration Number
DRKS00023583
Lead Sponsor
niversitätsklinikum Schleswig-Holstein Campus Kiel
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Full legal age, absence of hematological diseases, no medication with possible interactions with haematopoeisis, no chronically inflammatory diseases

Exclusion Criteria

Underlying hematological diseases, medication with possible interactions with haematopoesis, chronically inflammatory diseases, probably difficult conditions for bone marrow puncture

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
This project aims to define the developmental origin of the different molecular subtypes of ALL and to identify leukemia-specific gene expression in contrast to gene regulation during normal lymphopoiesis. Characterization of the disease-specific gene regulation will guide us to explore oncogenic signaling dependencies as novel therapeutic targets.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath